XRTX XORTX Therapeutics Inc.

Nasdaq xortx.com


$ 0.53 $ 0.01 (1.48 %)    

Friday, 21-Nov-2025 10:17:49 EST
QQQ $ 583.85 $ -3.59 (-0.61 %)
DIA $ 460.13 $ 0.72 (0.16 %)
SPY $ 653.41 $ -1.60 (-0.24 %)
TLT $ 89.50 $ -0.16 (-0.17 %)
GLD $ 374.22 $ 0.23 (0.06 %)
$ 0.528
$ 0.53
$ 0.52 x 1,000
$ 0.56 x 500
$ 0.53 - $ 0.53
$ 0.52 - $ 1.79
47,057
na
2M
$ 4.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

 xortx-therapeutics-issues-73871-shares-at-154-in-q1-2025-raising-net-proceeds-of-1097k-under-atm-program

Issuance of Shares under ATM OfferingIn other news, the Company confirms the issuance of 73,871 common shares at US$1.54 (CAD $...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

Core News & Articles

XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late stage cli...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION